Cargando…
Drug eruptions with novel targeted therapies – immune checkpoint and EGFR inhibitors
Given the increasing use of novel targeted therapies, dermatologists are constantly confronted with novel cutaneous side effects of these agents. A rapid diagnosis and appropriate management of these side effects are crucial to prevent impairment of the patients’ quality of life and interruptions of...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299005/ https://www.ncbi.nlm.nih.gov/pubmed/34811916 http://dx.doi.org/10.1111/ddg.14641 |